- Home
- STAI vs AEON Comparison
STAI vs AEON Comparison
Compare STAI & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.09
Company Overview
Basic Information| Metric | STAI | AEON |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 10.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STAI | AEON |
|---|---|---|
| Price | $3.30 | $1.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 173.3K | ★ 200.5K |
| Earning Date | 12-15-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,881,045.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 260.24 | N/A |
| 52 Week Low | $2.32 | $0.38 |
| 52 Week High | $181.40 | $42.48 |
Technical Indicators
Market Signals| Indicator | STAI | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 65.73 | 60.70 |
| Support Level | $2.32 | $0.72 |
| Resistance Level | $2.92 | $1.23 |
| Average True Range (ATR) | 0.57 | 0.11 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 70.93 | 70.10 |
Price Performance
Historical Comparison STAI
AEON
About STAI ScanTech AI Systems Inc.
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.